AKT1 and neoplasm: Though the signaling cascades downstream of CD44 is not well-characterized, it is known that CD44 activates different signaling pathways like Rho GTPases, Ras-MAPK, and PI3K/AKT pathways to regulate different tumor properties (Al-Othman et al., 2020).